Zambon

Zambon Group is a multinational pharmaceutical and chemical company founded in 1906, with headquarter in Bresso (Province of Milan), Italy. It operates directly on three continents - Europe, South America and Asia.

With over 2,300 employees in 16 countries and consolidated sales of € 480 million (+11%, about 80% generated outside Italy), the company has manufacturing plants in different countries including China for both fine chemicals and finished products, with production lines FDA approved.

History
Founded in Vicenza in 1906 by Gaetano Zambon, the Zambon Group operates on a global basis through its subsidiaries and commercial partners, with activities organised by business area: pharmaceutical, chemical and biomedical products. Currently the company is headquartered in Milan.

Organization
Zambon Group is made up of subsidiaries, partly owned companies and representative offices. It also has commercial relationships with world partners. Zambon Group operates in over 15 countries, via directly and indireclty owened companies, in over 50 countries, through commercial partnerships (licensees, distributors, agents). 80% of its turnover is generated outside Italy, has 2,300 employees in 16 countries and consolidated sales of € 480 million (+11%, about 80% generated outside Italy). The company has manufacturing plants in different countries, ranging from Italy to China.

Research & Development
Zambon's R&D, organized in 3 centres in Italy (Bresso and Vicenza) and Switzerland (Taverne), has developed activities in drug optimization (Taverne), pharmaceutical technology (Vicenza) and pre-clinical and clinical development (Bresso).

Products
Zambon's leading brands are Fluimucil, Monuril, and Spedifen.